Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: TheMaster who wrote (11111)	4/19/2012 1:43:04 PM
From: NTTG	2 Recommendations Read Replies (1) \| Respond to of 13111

Nice that they can get their work published, don't you think? Makes you wonder why others can not?

To: TheMaster who wrote (11111)	4/19/2012 2:04:17 PM
From: jm2i123	Respond to of 13111

"But now researchers are beginning to realize that certain types of chemotherapy and other biologic and targeted treatments may be stimulating a powerful immune response." Well some folks realize that a few years ago...and actually worked on it. I hear they have completed 2 trials already, are hopefully getting an SPA soon, and have many many patients already being treated... that can't be true?